Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/1988
03/22/1988US4733000 Oligopeptides for hypotensives
03/22/1988US4732972 Polypeptides having growth hormone releasing activity
03/22/1988US4732970 Antitumor amino acid and peptide derivatives of 1,4-bis(aminoalkyl and hydroxy-aminoalkyl)amino)-5,8-dihydroxyanthraquinones
03/22/1988US4732933 Neocarzinostatin complexes, a method for producing the same, and an antitumor agent containing said complexes as an active component
03/22/1988US4732891 Extraction of polypeptides
03/22/1988US4732890 Retro-inverso hexapeptide neurotensin analogs, process for their preparation and pharmaceutical compositions containing them
03/22/1988US4732889 Human erythropoietin
03/22/1988US4732864 Trace-labeled conjugates of metallothionein and target-seeking biologically active molecules
03/22/1988US4732863 PEG-modified antibody with reduced affinity for cell surface Fc receptors
03/22/1988US4732862 Anticancer antigens for humans
03/22/1988US4732763 Active/passive immunization of the internal female reproductive organs
03/22/1988US4732758 Preparation with collagenolytic activity having high activity and pharmaceutical compositions containing it
03/22/1988US4732757 Prevention and treatment of rheumatoid arthritis
03/22/1988US4732752 Polyvalent equine immune serum composition and method for treating rheumatoid arthritis
03/22/1988EP0218692A4 Von willebrand factor.
03/22/1988CA1234363A1 Monoclonal antibodies to surface recognition structure of mature human t lymphocyte clone
03/16/1988EP0260149A1 Human prorelaxin for therapeutic use
03/16/1988EP0260118A1 Selective amidination of diamines
03/16/1988EP0260006A1 Composition for inhibiting calculus formation and for dental hygiene
03/16/1988EP0259953A1 Cloning and expression of acidic fibroblast growth factor
03/16/1988EP0259904A1 Advanced anticancer therapy and cytotoxic medicaments for its implementation
03/16/1988EP0259893A2 Agents for removing advanced glycosylation endproducts
03/16/1988EP0259891A2 [Leu 13] motilin, DNAs coding for same and methods for producing same
03/16/1988EP0259863A2 Compositions for modulating the effect of TNF and IL-1
03/16/1988EP0259807A2 Complement-dependent cytolytic anti-trichomonas vaginalis monoclonal antibody and use thereof in therapy and in diagnosis
03/16/1988EP0259632A1 Expression of biologically active PDGF analogs in eucaryotic cells
03/16/1988EP0259615A1 Human low affinity Fc epsilon-receptor, the isolation, the recombinant preparation and purification thereof
03/16/1988EP0259564A2 A thymus derivative active after oral administration, methods of preparation and pharmaceutical compositions
03/16/1988EP0259438A1 Methods and materials for treatment of rheumatoid arthritis
03/16/1988EP0259425A1 Protein preservation
03/15/1988US4731439 Snake venom growth arresting peptide
03/15/1988US4731357 Promoting bone and/or tendon repair
03/15/1988US4731238 Novel monoclonal hybridoma and corresponding antibody
03/15/1988US4731237 Immune response to virus induced by anti-idiotype antibodies
03/15/1988CA1234101A1 Transferrin-vinca alkaloid cytotoxic compositions
03/15/1988CA1234100A1 Protein pp in20 xx, a process for obtaining it, and its use
03/15/1988CA1234047A1 Process for preparing the principal proteins of haemolyzed blood in the non-denatured form
03/10/1988WO1988001649A1 Single polypeptide chain binding molecules
03/10/1988WO1988001514A1 Monoclonal antibodies to fibrin
03/10/1988WO1988001512A1 Animal growth promotant
03/10/1988WO1988001511A1 Succinylated interleukin-2 for pharmaceutical compositions
03/10/1988WO1988001507A1 A method to treat blood
03/10/1988WO1988001506A1 Microgranular preparation useful in the delivery of biologically active materials to the intestinal regions of animals
03/10/1988WO1988001505A1 Scaled-up production of liposome-encapsulated hemoglobin
03/10/1988WO1988000837A3 Advanced anticancer therapy and cytotoxic medicaments for its implementation
03/09/1988EP0259212A1 Expression of a tumour-specific antigen by a recombinant viral vector, and its use to prevent or cure the corresponding tumour
03/09/1988EP0259197A1 Macromolecular conjugates of hemoglobin, process for preparing them and their uses
03/09/1988EP0259031A2 Human DNA in the diagnosis of retinoblastoma
03/09/1988EP0258817A2 Use of monoclonal antibody in tumor therapy
03/09/1988EP0258683A2 Administration forms for alpha-interferons
03/09/1988EP0258492A1 Human low affinity Fc epsilon-receptor, the isolation, the recombinant preparation and purification thereof
03/09/1988EP0258489A1 Human low affinity FC epsilon-receptor, the isolation and purification thereof
03/09/1988EP0258289A1 Peptide analogs
03/08/1988US4730050 Novel enzyme derivatives
03/08/1988US4729985 Hypotensive agents
03/08/1988US4729893 Enteric encapsulation of ancrod for oral administration
03/08/1988CA1233774A1 Monoclonal antibody to small cell carcinoma cells
03/08/1988CA1233773A1 Proteolytic procoagulant enzyme, antibodies thereto and use in cancer immunoassay
03/07/1988EP0241533A4 Rapid acting intravenous emulsions of omega-3 fatty acid esters.
03/03/1988DE3726517A1 Nasal compsn. contg. octreotide
03/03/1988DE3722098A1 Monoklonale antikoerper gegen pseudomonas aeruginosa flagella Monoclonal antibodies against Pseudomonas aeruginosa flagella
03/02/1988EP0258111A2 Novel neuronotrophic factor
03/02/1988EP0257992A2 Prophylactic and therapeutic agents for cerebral ischemia
03/02/1988EP0257956A2 Device and dispersion for intrapulmonary delivery of polypeptide growth factors and cytokines
03/02/1988EP0257950A2 method of inducing birds to molt
03/02/1988EP0257890A2 Antitumor agent
03/02/1988EP0257873A2 Method for purifying and isolating two ionic forms of somatomedin c
03/02/1988EP0257859A2 Novel combination
03/02/1988EP0257656A2 Antibacterial substance
03/02/1988EP0257485A2 Mixture of positively inotropically acting dihydropyridines and ACE inhibitors, and their use in medicaments
03/02/1988EP0257406A2 Recombinant B-cell differentiation factor
03/02/1988EP0257368A1 Compositions for parenteral administration and their use
03/02/1988EP0257312A2 A new cartilage-derived leukocyte elastase-inhibitor
03/02/1988EP0257114A1 Human low affinity Fc epsilon-receptor, the isolation and purification thereof
03/02/1988EP0133285B1 Crystal suspensions of insulin derivatives, process for their preparation and their use
03/02/1988CN87104988A Novel peptides
03/01/1988US4728726 GRF analogs IIIb
03/01/1988US4728725 Bradykinin potentiating pentapeptide; hypotensives, diagnostics
03/01/1988US4728640 Oligopeptide closely related to luteinizing hromone releasing hormone
03/01/1988US4728638 Somatostatine derivatives
03/01/1988US4728637 Complex of macromolecules extracted from mesenchymal cells for treating chronic degenerative disease
03/01/1988US4728614 Mutant human T cell line producing immunosuppressive factor and method for obtaining such mutants
03/01/1988CA1233414A1 Method for producing microcapsule
02/1988
02/25/1988WO1988001304A1 Dna encoding the t cell surface protein t4 and use of fragments of t4 in the treatment of aids
02/25/1988WO1988001297A1 Expression of g-csf and muteins thereof
02/25/1988WO1988001294A1 Process for separating single-strand tpa and double-strand tpa from each other
02/25/1988WO1988001292A1 Human enteric coronavirus
02/25/1988WO1988001213A1 Delivery systems for pharmacological agents
02/25/1988WO1988001176A1 Regulating animal reproduction
02/25/1988WO1988001175A1 Cofactor of prourokinase
02/25/1988WO1988001174A1 Glucagon fragment regulating calcium ion movement
02/25/1988WO1988001163A1 Topical radioprotective gel for mucosa
02/25/1988WO1988000836A3 Immuno-suppressor and process for its manufacture
02/25/1988WO1987003480A3 Medicament with anti-tumoral action containing hexadecylphosphocholine
02/24/1988EP0256989A1 Pharmaceutical administration systems containing chemotactic peptides
02/24/1988EP0256907A1 Protein synthesis inhibitor, process for its isolation, use, and pharmaceutial compositions containing it
02/24/1988EP0256847A2 Oxytocin and vasopressin antagonists
02/24/1988EP0256843A1 Expression of g-csf and muteins thereof and their use
02/24/1988EP0256836A1 Purification procedure of tPA from crude preparations
02/24/1988EP0256735A2 T cell-activating factor